Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israel, Tel Aviv
Tamar Sapra
39 anni di esperienza
Clinica certificata da :
Keytruda (pembrolizumab) is the first FDA approved immunotherapy drug that blocks the protein - receptor (programmed cell death - PD-1) allowing patients immune system to attack cancer.
Israel is one of the few countries allowed to use Keytruda not only for melanoma, but also as a new first-line treatment for lung cancer and for metastatic or recurrent small-cell neck or head carcinoma. Keytruda has been officially used in Israel since 2014 and has become a part of a "essential medicines package" in the following year.
The Israeli medical centers involved in the clinical trials of the drug detected improvement of treatment of melanoma without the side effects caused by traditional chemotherapy (like hair loss). The drugs also have shown promise as a “long-lasting” treatment for selected oncological diseases, but doctors continue to learn more as the drugs are used outside of clinical trials.
Tested at Sheba Medical Center, Keytruda deals with tumors using the body’s own immune system. An Israeli-tested drug was a key in helping former US president Jimmy Carter in his fight with life-threatening tumors after he was diagnosed with melanoma at the end of 2015.
The course of treatment for each patient is different. Israeli oncologists determine the number of procedures based on experience in chemotherapy and patient's general medical state.
| Israel | Turchia | Austria | |
| Immunotherapy with Keytruda (Pembolizumab) | - | da $3,300 | da $15,000 |
Revisionato medicalmente da
Fahad MawloodDay 1
Day 2
Day 3
Day 4-5
Day 6
Day 7
Weeks 2-4
Please note that each patient"s experience may vary, and you should always follow the advice of your healthcare provider.
As the leading global medical tourism platform, Bookimed.com takes responsibility for providing reliable information to our clients, including patients and medical centers. All the information provided on our website is grounded in research, foresight, and expertise, and meets high interest related to the product and follows:
We form our listings of clinics and doctors with strict regulations of our smart automatic ranking system. The system is based on real Bookimed patient rates to provide the most objective and transparent information about clinics and medical services, including Immunotherapy with Keytruda (Pembolizumab) in Israel.
Our experienced data scientist collects data daily, monitors and optimizes the ranking system using machine learning and artificial intelligence to ensure that the ranking system is up-to-date and provides accurate results.
We collect the opinions of Bookimed clients only after getting medical experience with the clinic — so everyone on the platform can trust the facility they choose, including for Immunotherapy with Keytruda (Pembolizumab) in Israel. We strive to make the content on our platform as useful as possible and ensure the freedom to express critical opinions. Thus, we publish positive and negative reviews, aiming at being a source for informed decision-making for our future clients.
On Bookimed.com, you may find choice and convenience in finding the best medical solutions from top medical services providers, including those offering Immunotherapy with Keytruda (Pembolizumab) in Israel, just in one place, and often at competitive prices. Making sure to deliver the freshest information, the clinic’s representatives update doctors’ CVs, clinics’ capacities, before-after pictures, prices, packages, and specials by themselves shortly. You may meet the clinic’s representative and check the date of updated content on every clinic’s page to make sure of its trustworthiness.
Our blog and supportive pieces are created by professional authors with at least 3-year experience in medical writing and edited by medical specialists with relevant clinical and research expertise — all carefully recruited to the team. We strive to enhance patient access to health information, making it expert but easy to understand. All pieces follow the Bookimed’s Editorial Guidelines.
We are made of people and for people — and that"s our core value. That"s why all the data presented on the platform is collected, edited, reviewed, and updated regularly by our patients, our partner clinics, and our team, including the Bookimed Medical Advisory Board, which consists of the world-renowned doctors with value expertise over 20 years of practice, and a positive reputation. Learn more about us and our mission.
In case you find any mistake or have any questions on the information presented on Bookimed.com related to Immunotherapy with Keytruda (Pembolizumab) in Israel, please feel free to contact us at marketing@bookimed.com.
Dr. Pelles Sharon specializes in immunotherapy with Keytruda at Sourasky Medical Center, bringing extensive research and clinical expertise to cancer treatment.
Prof. Merimsky leads the Soft Tissue and Bone Oncology Unit at Sourasky Medical Center – a pioneer in immunotherapy research for sarcoma.
Principal investigator of clinical trials in cancer therapies – Dr. Sarid brings cutting-edge immunotherapy expertise to Sourasky Medical Center.
Dr. Ram Ron specializes in Immunotherapy with Keytruda (Pembrolizumab) at Sourasky Medical Center (Ichilov), offering advanced treatment options.
Keytruda, a form of immune-based therapy, leverages the body's immune system to target and destroy cancer cells using monoclonal antibodies.